Effective Models of HCV Care - Testing, Evaluation and Treatment
Einstein/Montefiore Department of Medicine Grand Rounds
Thursday, April 11, 2013
8:00 AM: Forchheimer Medical Science Building 3rd Fl Lecture Hall
Speaker & Info
Alain Litwin, MD
Associate Professor of Clinical Medicine, Department of Medicine (General
Associate Professor of Clinical Psychiatry & Behavioral Sciences,
Department of Psychiatry and Behavioral Sciences
Repeated at 12:15 pm, Cherkasky Auditorium, Montefiore Medical Center
With funding from NIH, CDC, AHRQ, the Robert Wood Johnson Foundation, New York State Department of Health, New York City Department of Health, and industry, Dr. Alain Litwin’s research is focused on developing and studying models of hepatitis C virus (HCV) care for drug users, and on advocating for increasing access to effective care for HCV-infected patients. Dr. Litwin has worked with government and community organizations on efforts to expand access to HCV treatment and has collaborated on policy statements, clinical guidelines, task forces, strategic plans, and educational curricula with the New York City Department of Health and Mental Hygiene, New York State Department of Health, Substance Abuse and Mental Health Service Administration, Center for Substance Abuse Treatment, Centers for Disease Control and Prevention, and the American Society of Addiction Medicine.
Dr. Litwin is board certified in internal medicine and addiction medicine, and has been providing medical care to drug users with complex social, psychiatric and medical needs within an integrated primary care and methadone maintenance treatment program for thirteen years. After joining Einstein’s Division of Substance Abuse (DoSA), he helped develop a comprehensive on-site HCV treatment program, including HCV support groups and a peer educator program, to improve medical care of HCV-infected drug users.
After attending this activity, participants will be able to:
- Understand risk-based and birth cohort strategies for HCV testing
- Learn about effective models of care for evaluating and treating drug users with chronic hepatitis C
- Understand public health implications of future interferon-free therapies for patients with chronic hepatitis C
Accreditation: Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
Division of General Internal Medicine (Department of Medicine)